These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 29318144)

  • 1. The Role of Serum Adiponectin for Outcome Prediction in Patients with Dilated Cardiomyopathy and Advanced Heart Failure.
    Baltrūnienė V; Bironaitė D; Kažukauskienė I; Bogomolovas J; Vitkus D; Ručinskas K; Žurauskas E; Augulis R; Grabauskienė V
    Biomed Res Int; 2017; 2017():3818292. PubMed ID: 29318144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Cardiac T-Cadherin in the Indicating Heart Failure Severity of Patients with Non-Ischemic Dilated Cardiomyopathy.
    Baltrūnienė V; Rinkūnaitė I; Bogomolovas J; Bironaitė D; Kažukauskienė I; Šimoliūnas E; Ručinskas K; Puronaitė R; Bukelskienė V; Grabauskienė AV
    Medicina (Kaunas); 2020 Jan; 56(1):. PubMed ID: 31936691
    [No Abstract]   [Full Text] [Related]  

  • 3. Longitudinal strain combined with delayed-enhancement magnetic resonance improves risk stratification in patients with dilated cardiomyopathy.
    Chimura M; Onishi T; Tsukishiro Y; Sawada T; Kiuchi K; Shimane A; Okajima K; Yamada S; Taniguchi Y; Yasaka Y; Kawai H
    Heart; 2017 May; 103(9):679-686. PubMed ID: 27799316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone Modification Is Correlated With Reverse Left Ventricular Remodeling in Nonischemic Dilated Cardiomyopathy.
    Ito E; Miyagawa S; Fukushima S; Yoshikawa Y; Saito S; Saito T; Harada A; Takeda M; Kashiyama N; Nakamura Y; Shiozaki M; Toda K; Sawa Y
    Ann Thorac Surg; 2017 Nov; 104(5):1531-1539. PubMed ID: 28760462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic impact of dynamic ventricular dyssynchrony in patients with idiopathic dilated cardiomyopathy and narrow QRS.
    D'Andrea A; Mele D; Nistri S; Riegler L; Galderisi M; Agricola E; Losi MA; Ballo P; Mondillo S; Badano LP;
    Eur Heart J Cardiovasc Imaging; 2013 Feb; 14(2):183-9. PubMed ID: 22872513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Impact of Hypertrabeculation and Noncompaction Phenotype in Dilated Cardiomyopathy: A CMR Study.
    Amzulescu MS; Rousseau MF; Ahn SA; Boileau L; de Meester de Ravenstein C; Vancraeynest D; Pasquet A; Vanoverschelde JL; Pouleur AC; Gerber BL
    JACC Cardiovasc Imaging; 2015 Aug; 8(8):934-46. PubMed ID: 26189121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ischemic versus nonischemic dilated cardiomyopathy: the implications of heart failure etiology on left ventricular assist device outcomes.
    Tsiouris A; Borgi J; Karam J; Nemeh HW; Paone G; Brewer RJ; Morgan JA
    ASAIO J; 2013; 59(2):130-5. PubMed ID: 23438774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of cardiac stability after weaning from left ventricular assist devices in patients with idiopathic dilated cardiomyopathy.
    Dandel M; Weng Y; Siniawski H; Potapov E; Drews T; Lehmkuhl HB; Knosalla C; Hetzer R
    Circulation; 2008 Sep; 118(14 Suppl):S94-105. PubMed ID: 18824777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurohormonal and echocardiographic results after CorCap and mitral annuloplasty for dilated cardiomyopathy.
    Rubino AS; Onorati F; Santarpino G; Pasceri E; Santarpia G; Cristodoro L; Serraino GF; Renzulli A
    Ann Thorac Surg; 2009 Sep; 88(3):719-25. PubMed ID: 19699885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term results in patients with idiopathic dilated cardiomyopathy after weaning from left ventricular assist devices.
    Dandel M; Weng Y; Siniawski H; Potapov E; Lehmkuhl HB; Hetzer R
    Circulation; 2005 Aug; 112(9 Suppl):I37-45. PubMed ID: 16159848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Echocardiography-derived variables predict outcome in patients with nonischemic dilated cardiomyopathy with or without a restrictive filling pattern.
    Faris R; Coats AJ; Henein MY
    Am Heart J; 2002 Aug; 144(2):343-50. PubMed ID: 12177655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum Galectin-3 and ST2 as predictors of unfavorable outcome in stable dilated cardiomyopathy patients.
    Wojciechowska C; Romuk E; Nowalany-Kozielska E; Jacheć W
    Hellenic J Cardiol; 2017; 58(5):350-359. PubMed ID: 28363768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural history of dilated cardiomyopathy: from asymptomatic left ventricular dysfunction to heart failure--a subgroup analysis from the Trieste Cardiomyopathy Registry.
    Aleksova A; Sabbadini G; Merlo M; Pinamonti B; Barbati G; Zecchin M; Bussani R; Silvestri F; Iorio AM; Stolfo D; Dal Ferro M; Dragos AM; Meringolo G; Pyxaras S; Lo Giudice F; Perkan A; di Lenarda A; Sinagra G
    J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):699-705. PubMed ID: 19474760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of left atrial volume in patients with dilated cardiomyopathy.
    Ferreira F; Galrinho A; Soares R; Branco L; Abreu J; Feliciano J; Papoila AL; Virella D; Leal A; Cruz Ferreira R
    Rev Port Cardiol; 2013 Nov; 32(11):865-72. PubMed ID: 24119867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart failure biomarkers in patients with dilated cardiomyopathy.
    Bielecka-Dabrowa A; von Haehling S; Aronow WS; Ahmed MI; Rysz J; Banach M
    Int J Cardiol; 2013 Oct; 168(3):2404-10. PubMed ID: 23416015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incremental prognostic values of serum tenascin-C levels with blood B-type natriuretic peptide testing at discharge in patients with dilated cardiomyopathy and decompensated heart failure.
    Fujimoto N; Onishi K; Sato A; Terasaki F; Tsukada B; Nozato T; Yamada T; Imanaka-Yoshida K; Yoshida T; Ito M; Hiroe M
    J Card Fail; 2009 Dec; 15(10):898-905. PubMed ID: 19944367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fine-tuning management of the Heart Assist 5 left ventricular assist device with two- and three-dimensional echocardiography.
    Demirozu ZT; Arat N; Kucukaksu DS
    Cardiovasc J Afr; 2016; 27(4):208-212. PubMed ID: 27841907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of tissue Doppler right ventricular systolic and diastolic function indexes combined with plasma B-type natriuretic Peptide in patients with advanced heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Bistola V; Parissis JT; Paraskevaidis I; Panou F; Nikolaou M; Ikonomidis I; Flessas N; Filippatos G; Iliodromitis E; Kremastinos DT
    Am J Cardiol; 2010 Jan; 105(2):249-54. PubMed ID: 20102927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of dyslipidaemia in patients with heart failure of unexplained aetiology.
    Skwarek M; Bilińska ZT; Mazurkiewicz Ł; Grzybowski J; Kruk M; Kurjata P; Piotrowski W; Ruzyłło W
    Kardiol Pol; 2008 May; 66(5):515-22, discussion 523-4. PubMed ID: 18537059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-terminal pro brain natriuretic peptide to predict prognosis in dilated cardiomyopathy with sinus rhythm.
    Tigen K; Karaahmet T; Kahveci G; Tanalp AC; Bitigen A; Fotbolcu H; Bayrak F; Mutlu B; Basaran Y
    Heart Lung Circ; 2007 Aug; 16(4):290-4. PubMed ID: 17403613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.